Osaic Holdings

Osaic Holdings’s Crescent Biopharma CBIO Stock Holding History

Osaic Holdings’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$477	Hold	26	–	–	﹤0.01%	7447
2025 Q4	$308	Hold	26	–	–	﹤0.01%	7516
2025 Q3	$374	Buy	+26	New	+$345	﹤0.01%	7598
2023 Q1	–	Sell	-6	Closed	-$2K	–	7529
2022 Q4	$2K	Hold	6	–	–	﹤0.01%	6651
2022 Q3	$0	Hold	6	–	–	﹤0.01%	7344
2022 Q2	$0	Hold	6	–	–	﹤0.01%	7440
2022 Q1	$490K	Hold	6	–	–	﹤0.01%	3241
2021 Q4	$1K	Sell	6 -5	-45%	-$907	﹤0.01%	7181
2021 Q3	$2K	Hold	11	–	–	﹤0.01%	6851
2021 Q2	$3K	Hold	11	–	–	﹤0.01%	6588
2021 Q1	$3K	Hold	11	–	–	﹤0.01%	6364
2020 Q4	$4K	Buy	+11	New	+$3.85K	﹤0.01%	5845

Other funds holding CBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM